img

Global Peptide-based Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Peptide-based Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are distinguished from proteins on the basis of size, and as a benchmark can be understood to contain approximately 50 amino acids or less.
Peptide-based Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Peptide-based Drug market is projected to reach US$ 62200 million in 2029, increasing from US$ 35410 million in 2022, with the CAGR of 9.0% during the period of 2024 to 2029. Demand from Cancer and Metabolic Disorders are the major drivers for the industry.
The Peptide Drug market is driven by the increasing recognition of peptides as a versatile and promising class of therapeutics. Peptides offer the potential to target specific biological pathways and cellular functions with high specificity, making them valuable candidates for treating a wide range of diseases, including cancer, metabolic disorders, and cardiovascular conditions. The growing understanding of peptide structure-activity relationships, coupled with advancements in peptide synthesis and modification techniques, contribute to the development of more stable and bioavailable peptide drugs, fostering market growth. Moreover, the rise in personalized medicine approaches and the need for more targeted therapies align with the development of peptide-based treatments that can be tailored to individual patient profiles. However, the market also faces challenges, including optimizing peptide delivery systems, enhancing bioavailability, and addressing potential immunogenicity and stability issues. Additionally, the complexity of peptide synthesis, the need for stringent regulatory approvals, and the competition from other therapeutic modalities pose obstacles for manufacturers and researchers. To succeed, stakeholders must focus on innovative peptide design, efficient synthesis methods, and comprehensive pre-clinical and clinical studies to demonstrate the safety and efficacy of peptide drugs. Addressing challenges while harnessing the therapeutic potential of peptides will be essential for driving the growth and adoption of peptide-based treatments in various medical applications.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Peptide-based Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
AbbVie
Ipsen
Ferring
Merck
The Medicines
J & J
Segment by Type
Injection
Oral
Other

Segment by Application


Cancer
Metabolic Disorders
Central Nervous System
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Peptide-based Drug market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Peptide-based Drug introduction, etc. Peptide-based Drug Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Peptide-based Drug market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Peptide-based Drug
1.1 Peptide-based Drug Market Overview
1.1.1 Peptide-based Drug Product Scope
1.1.2 Peptide-based Drug Market Status and Outlook
1.2 Global Peptide-based Drug Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Peptide-based Drug Market Size by Region (2018-2029)
1.4 Global Peptide-based Drug Historic Market Size by Region (2018-2024)
1.5 Global Peptide-based Drug Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Peptide-based Drug Market Size (2018-2029)
1.6.1 North America Peptide-based Drug Market Size (2018-2029)
1.6.2 Europe Peptide-based Drug Market Size (2018-2029)
1.6.3 Asia-Pacific Peptide-based Drug Market Size (2018-2029)
1.6.4 Latin America Peptide-based Drug Market Size (2018-2029)
1.6.5 Middle East & Africa Peptide-based Drug Market Size (2018-2029)
2 Peptide-based Drug Market by Type
2.1 Introduction
2.1.1 Injection
2.1.2 Oral
2.1.3 Other
2.2 Global Peptide-based Drug Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Peptide-based Drug Historic Market Size by Type (2018-2024)
2.2.2 Global Peptide-based Drug Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Peptide-based Drug Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Peptide-based Drug Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Peptide-based Drug Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Peptide-based Drug Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Peptide-based Drug Revenue Breakdown by Type (2018-2029)
3 Peptide-based Drug Market Overview by Application
3.1 Introduction
3.1.1 Cancer
3.1.2 Metabolic Disorders
3.1.3 Central Nervous System
3.1.4 Other
3.2 Global Peptide-based Drug Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Peptide-based Drug Historic Market Size by Application (2018-2024)
3.2.2 Global Peptide-based Drug Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Peptide-based Drug Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Peptide-based Drug Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Peptide-based Drug Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Peptide-based Drug Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Peptide-based Drug Revenue Breakdown by Application (2018-2029)
4 Peptide-based Drug Competition Analysis by Players
4.1 Global Peptide-based Drug Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Peptide-based Drug as of 2022)
4.3 Date of Key Players Enter into Peptide-based Drug Market
4.4 Global Top Players Peptide-based Drug Headquarters and Area Served
4.5 Key Players Peptide-based Drug Product Solution and Service
4.6 Competitive Status
4.6.1 Peptide-based Drug Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Sanofi
5.1.1 Sanofi Profile
5.1.2 Sanofi Main Business
5.1.3 Sanofi Peptide-based Drug Products, Services and Solutions
5.1.4 Sanofi Peptide-based Drug Revenue (US$ Million) & (2018-2024)
5.1.5 Sanofi Recent Developments
5.2 Teva
5.2.1 Teva Profile
5.2.2 Teva Main Business
5.2.3 Teva Peptide-based Drug Products, Services and Solutions
5.2.4 Teva Peptide-based Drug Revenue (US$ Million) & (2018-2024)
5.2.5 Teva Recent Developments
5.3 Novo Nordisk
5.3.1 Novo Nordisk Profile
5.3.2 Novo Nordisk Main Business
5.3.3 Novo Nordisk Peptide-based Drug Products, Services and Solutions
5.3.4 Novo Nordisk Peptide-based Drug Revenue (US$ Million) & (2018-2024)
5.3.5 Takeda Recent Developments
5.4 Takeda
5.4.1 Takeda Profile
5.4.2 Takeda Main Business
5.4.3 Takeda Peptide-based Drug Products, Services and Solutions
5.4.4 Takeda Peptide-based Drug Revenue (US$ Million) & (2018-2024)
5.4.5 Takeda Recent Developments
5.5 Eli Lilly
5.5.1 Eli Lilly Profile
5.5.2 Eli Lilly Main Business
5.5.3 Eli Lilly Peptide-based Drug Products, Services and Solutions
5.5.4 Eli Lilly Peptide-based Drug Revenue (US$ Million) & (2018-2024)
5.5.5 Eli Lilly Recent Developments
5.6 AstraZeneca
5.6.1 AstraZeneca Profile
5.6.2 AstraZeneca Main Business
5.6.3 AstraZeneca Peptide-based Drug Products, Services and Solutions
5.6.4 AstraZeneca Peptide-based Drug Revenue (US$ Million) & (2018-2024)
5.6.5 AstraZeneca Recent Developments
5.7 Novartis
5.7.1 Novartis Profile
5.7.2 Novartis Main Business
5.7.3 Novartis Peptide-based Drug Products, Services and Solutions
5.7.4 Novartis Peptide-based Drug Revenue (US$ Million) & (2018-2024)
5.7.5 Novartis Recent Developments
5.8 AbbVie
5.8.1 AbbVie Profile
5.8.2 AbbVie Main Business
5.8.3 AbbVie Peptide-based Drug Products, Services and Solutions
5.8.4 AbbVie Peptide-based Drug Revenue (US$ Million) & (2018-2024)
5.8.5 AbbVie Recent Developments
5.9 Ipsen
5.9.1 Ipsen Profile
5.9.2 Ipsen Main Business
5.9.3 Ipsen Peptide-based Drug Products, Services and Solutions
5.9.4 Ipsen Peptide-based Drug Revenue (US$ Million) & (2018-2024)
5.9.5 Ipsen Recent Developments
5.10 Ferring
5.10.1 Ferring Profile
5.10.2 Ferring Main Business
5.10.3 Ferring Peptide-based Drug Products, Services and Solutions
5.10.4 Ferring Peptide-based Drug Revenue (US$ Million) & (2018-2024)
5.10.5 Ferring Recent Developments
5.11 Merck
5.11.1 Merck Profile
5.11.2 Merck Main Business
5.11.3 Merck Peptide-based Drug Products, Services and Solutions
5.11.4 Merck Peptide-based Drug Revenue (US$ Million) & (2018-2024)
5.11.5 Merck Recent Developments
5.12 The Medicines
5.12.1 The Medicines Profile
5.12.2 The Medicines Main Business
5.12.3 The Medicines Peptide-based Drug Products, Services and Solutions
5.12.4 The Medicines Peptide-based Drug Revenue (US$ Million) & (2018-2024)
5.12.5 The Medicines Recent Developments
5.13 J & J
5.13.1 J & J Profile
5.13.2 J & J Main Business
5.13.3 J & J Peptide-based Drug Products, Services and Solutions
5.13.4 J & J Peptide-based Drug Revenue (US$ Million) & (2018-2024)
5.13.5 J & J Recent Developments
6 North America
6.1 North America Peptide-based Drug Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Peptide-based Drug Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Peptide-based Drug Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Peptide-based Drug Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Peptide-based Drug Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Peptide-based Drug Market Dynamics
11.1 Peptide-based Drug Industry Trends
11.2 Peptide-based Drug Market Drivers
11.3 Peptide-based Drug Market Challenges
11.4 Peptide-based Drug Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Peptide-based Drug Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Peptide-based Drug Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Peptide-based Drug Market Size Share by Region (2018-2024)
Table 4. Global Peptide-based Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Peptide-based Drug Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Peptide-based Drug Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Peptide-based Drug Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Peptide-based Drug Revenue Market Share by Type (2018-2024)
Table 9. Global Peptide-based Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Peptide-based Drug Revenue Market Share by Type (2024-2029)
Table 11. North America Peptide-based Drug Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Peptide-based Drug Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe Peptide-based Drug Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Peptide-based Drug Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific Peptide-based Drug Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Peptide-based Drug Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America Peptide-based Drug Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Peptide-based Drug Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa Peptide-based Drug Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Peptide-based Drug Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global Peptide-based Drug Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global Peptide-based Drug Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Peptide-based Drug Revenue Market Share by Application (2018-2024)
Table 24. Global Peptide-based Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Peptide-based Drug Revenue Market Share by Application (2024-2029)
Table 26. North America Peptide-based Drug Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Peptide-based Drug Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe Peptide-based Drug Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Peptide-based Drug Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific Peptide-based Drug Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Peptide-based Drug Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America Peptide-based Drug Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Peptide-based Drug Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa Peptide-based Drug Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Peptide-based Drug Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Peptide-based Drug Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Peptide-based Drug Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Peptide-based Drug as of 2022)
Table 39. Date of Key Players Enter into Peptide-based Drug Market
Table 40. Global Peptide-based Drug Key Players Headquarters and Area Served
Table 41. Peptide-based Drug Product Solution and Service
Table 42. Global Peptide-based Drug Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Sanofi Basic Information List
Table 45. Sanofi Description and Business Overview
Table 46. Sanofi Peptide-based Drug Products, Services and Solutions
Table 47. Revenue (US$ Million) in Peptide-based Drug Business of Sanofi (2018-2024)
Table 48. Sanofi Recent Developments
Table 49. Teva Basic Information List
Table 50. Teva Description and Business Overview
Table 51. Teva Peptide-based Drug Products, Services and Solutions
Table 52. Revenue (US$ Million) in Peptide-based Drug Business of Teva (2018-2024)
Table 53. Teva Recent Developments
Table 54. Novo Nordisk Basic Information List
Table 55. Novo Nordisk Description and Business Overview
Table 56. Novo Nordisk Peptide-based Drug Products, Services and Solutions
Table 57. Revenue (US$ Million) in Peptide-based Drug Business of Novo Nordisk (2018-2024)
Table 58. Novo Nordisk Recent Developments
Table 59. Takeda Basic Information List
Table 60. Takeda Description and Business Overview
Table 61. Takeda Peptide-based Drug Products, Services and Solutions
Table 62. Revenue (US$ Million) in Peptide-based Drug Business of Takeda (2018-2024)
Table 63. Takeda Recent Developments
Table 64. Eli Lilly Basic Information List
Table 65. Eli Lilly Description and Business Overview
Table 66. Eli Lilly Peptide-based Drug Products, Services and Solutions
Table 67. Revenue (US$ Million) in Peptide-based Drug Business of Eli Lilly (2018-2024)
Table 68. Eli Lilly Recent Developments
Table 69. AstraZeneca Basic Information List
Table 70. AstraZeneca Description and Business Overview
Table 71. AstraZeneca Peptide-based Drug Products, Services and Solutions
Table 72. Revenue (US$ Million) in Peptide-based Drug Business of AstraZeneca (2018-2024)
Table 73. AstraZeneca Recent Developments
Table 74. Novartis Basic Information List
Table 75. Novartis Description and Business Overview
Table 76. Novartis Peptide-based Drug Products, Services and Solutions
Table 77. Revenue (US$ Million) in Peptide-based Drug Business of Novartis (2018-2024)
Table 78. Novartis Recent Developments
Table 79. AbbVie Basic Information List
Table 80. AbbVie Description and Business Overview
Table 81. AbbVie Peptide-based Drug Products, Services and Solutions
Table 82. Revenue (US$ Million) in Peptide-based Drug Business of AbbVie (2018-2024)
Table 83. AbbVie Recent Developments
Table 84. Ipsen Basic Information List
Table 85. Ipsen Description and Business Overview
Table 86. Ipsen Peptide-based Drug Products, Services and Solutions
Table 87. Revenue (US$ Million) in Peptide-based Drug Business of Ipsen (2018-2024)
Table 88. Ipsen Recent Developments
Table 89. Ferring Basic Information List
Table 90. Ferring Description and Business Overview
Table 91. Ferring Peptide-based Drug Products, Services and Solutions
Table 92. Revenue (US$ Million) in Peptide-based Drug Business of Ferring (2018-2024)
Table 93. Ferring Recent Developments
Table 94. Merck Basic Information List
Table 95. Merck Description and Business Overview
Table 96. Merck Peptide-based Drug Products, Services and Solutions
Table 97. Revenue (US$ Million) in Peptide-based Drug Business of Merck (2018-2024)
Table 98. Merck Recent Developments
Table 99. The Medicines Basic Information List
Table 100. The Medicines Description and Business Overview
Table 101. The Medicines Peptide-based Drug Products, Services and Solutions
Table 102. Revenue (US$ Million) in Peptide-based Drug Business of The Medicines (2018-2024)
Table 103. The Medicines Recent Developments
Table 104. J & J Basic Information List
Table 105. J & J Description and Business Overview
Table 106. J & J Peptide-based Drug Products, Services and Solutions
Table 107. Revenue (US$ Million) in Peptide-based Drug Business of J & J (2018-2024)
Table 108. J & J Recent Developments
Table 109. North America Peptide-based Drug Market Size by Country (2018-2024) & (US$ Million)
Table 110. North America Peptide-based Drug Market Size by Country (2024-2029) & (US$ Million)
Table 111. Europe Peptide-based Drug Market Size by Country (2018-2024) & (US$ Million)
Table 112. Europe Peptide-based Drug Market Size by Country (2024-2029) & (US$ Million)
Table 113. Asia-Pacific Peptide-based Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 114. Asia-Pacific Peptide-based Drug Market Size by Region (2018-2024) & (US$ Million)
Table 115. Asia-Pacific Peptide-based Drug Market Size by Region (2024-2029) & (US$ Million)
Table 116. Asia-Pacific Peptide-based Drug Market Share by Region (2018-2024)
Table 117. Asia-Pacific Peptide-based Drug Market Share by Region (2024-2029)
Table 118. Latin America Peptide-based Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 119. Latin America Peptide-based Drug Market Size by Country (2018-2024) & (US$ Million)
Table 120. Latin America Peptide-based Drug Market Size by Country (2024-2029) & (US$ Million)
Table 121. Middle East & Africa Peptide-based Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 122. Middle East & Africa Peptide-based Drug Market Size by Country (2018-2024) & (US$ Million)
Table 123. Middle East & Africa Peptide-based Drug Market Size by Country (2024-2029) & (US$ Million)
Table 124. Peptide-based Drug Market Trends
Table 125. Peptide-based Drug Market Drivers
Table 126. Peptide-based Drug Market Challenges
Table 127. Peptide-based Drug Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peptide-based Drug Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Peptide-based Drug Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Peptide-based Drug Market Share by Regions: 2022 VS 2029
Figure 4. Global Peptide-based Drug Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Peptide-based Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Peptide-based Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Peptide-based Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Peptide-based Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Peptide-based Drug Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of Injection
Figure 11. Global Injection Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of Oral
Figure 13. Global Oral Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Product Picture of Other
Figure 15. Global Other Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 16. Global Peptide-based Drug Market Size Share by Type: 2022 & 2029
Figure 17. North America Peptide-based Drug Revenue Market Share by Type (2018-2029)
Figure 18. Europe Peptide-based Drug Revenue Market Share by Type (2018-2029)
Figure 19. Asia-Pacific Peptide-based Drug Revenue Market Share by Type (2018-2029)
Figure 20. Latin America Peptide-based Drug Revenue Market Share by Type (2018-2029)
Figure 21. Middle East and Africa Peptide-based Drug Revenue Market Share by Type (2018-2029)
Figure 22. Cancer Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 23. Metabolic Disorders Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 24. Central Nervous System Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 25. Other Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 26. Global Peptide-based Drug Market Size Share by Application: 2022 & 2029
Figure 27. North America Peptide-based Drug Revenue Market Share by Application (2018-2029)
Figure 28. Europe Peptide-based Drug Revenue Market Share by Application (2018-2029)
Figure 29. Asia-Pacific Peptide-based Drug Revenue Market Share by Application (2018-2029)
Figure 30. Latin America Peptide-based Drug Revenue Market Share by Application (2018-2029)
Figure 31. Middle East and Africa Peptide-based Drug Revenue Market Share by Application (2018-2029)
Figure 32. Peptide-based Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 33. Global Top 5 and Top 10 Players Peptide-based Drug Market Share in 2022
Figure 34. North America Peptide-based Drug Market Share by Country (2018-2029)
Figure 35. United States Peptide-based Drug Market Size (2018-2029) & (US$ Million)
Figure 36. Canada Peptide-based Drug Market Size (2018-2029) & (US$ Million)
Figure 37. Germany Peptide-based Drug Market Size (2018-2029) & (US$ Million)
Figure 38. France Peptide-based Drug Market Size (2018-2029) & (US$ Million)
Figure 39. U.K. Peptide-based Drug Market Size (2018-2029) & (US$ Million)
Figure 40. Italy Peptide-based Drug Market Size (2018-2029) & (US$ Million)
Figure 41. Russia Peptide-based Drug Market Size (2018-2029) & (US$ Million)
Figure 42. Nordic Countries Peptide-based Drug Market Size (2018-2029) & (US$ Million)
Figure 43. Asia-Pacific Peptide-based Drug Market Share by Region (2018-2029)
Figure 44. China Peptide-based Drug Market Size (2018-2029) & (US$ Million)
Figure 45. Japan Peptide-based Drug Market Size (2018-2029) & (US$ Million)
Figure 46. South Korea Peptide-based Drug Market Size (2018-2029) & (US$ Million)
Figure 47. Southeast Asia Peptide-based Drug Market Size (2018-2029) & (US$ Million)
Figure 48. India Peptide-based Drug Market Size (2018-2029) & (US$ Million)
Figure 49. Australia Peptide-based Drug Market Size (2018-2029) & (US$ Million)
Figure 50. Latin America Peptide-based Drug Market Share by Country (2018-2029)
Figure 51. Mexico Peptide-based Drug Market Size (2018-2029) & (US$ Million)
Figure 52. Brazil Peptide-based Drug Market Size (2018-2029) & (US$ Million)
Figure 53. Middle East & Africa Peptide-based Drug Market Share by Country (2018-2029)
Figure 54. Turkey Peptide-based Drug Market Size (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Peptide-based Drug Market Size (2018-2029) & (US$ Million)
Figure 56. UAE Peptide-based Drug Market Size (2018-2029) & (US$ Million)
Figure 57. Bottom-up and Top-down Approaches for This Report